drugset / Trial / NCT03398473

A Study Comparing The Effects Of Epoetin Hospira Single-Dose Vial (SDV) And Multi-Dose Vial (MDV) When Administered Subcutaneously To Normal Healthy Subjects

NCT03398473

Phase 1 Completed 68 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

This study will assess the PK similarity of epoetin administered as Hospira MDV versus Hospira SDV by conducting a single-dose comparative evaluation in normal healthy subjects enrolled at a single center.

Timeline

Start
2018-01-25
Primary completion
2018-04-11
Completion
2018-05-07

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic Subcutaneous

Indications

No indication recorded.